This page shows the publications co-authored by Jonathan Li and Raymond Chung.
Type I, II, and III interferon signatures correspond to COVID-19 disease severity. J Infect Dis. 2021 May 24.
Type I, II, and III interferon signatures correspond to COVID-19 disease severity. medRxiv. 2021 Mar 12.
Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity. J Infect Dis. 2021 09 01; 224(5):777-782.
Mobile Health (mHealth) Viral Diagnostics Enabled with Adaptive Adversarial Learning. ACS Nano. 2021 01 26; 15(1):665-673.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.